An efficient and scalable synthesis of the potent CETP inhibitor, (2R,S)-3,4-dihydro-2-[3-(1,1,2,2-tetrafluoroethoxy)phenyl]-5-[3-(trifluoromethoxy)phenyl]...
An efficient and scalable synthesis of the potent CETP inhibitor, (2R,S)-3,4-dihydro-2-[3-(1,1,2,2-tetrafluoroethoxy)phenyl]-5-[3-(trifluoromethoxy)phenyl]...
An efficient and scalable synthesis of the potent CETP inhibitor, (2R,S)-3,4-dihydro-2-[3-(1,1,2,2-tetrafluoroethoxy)phenyl]-5-[3-(trifluoromethoxy)phenyl]...
In our previous work, compound 5 was discovered as a moderate CETP inhibitor. The replacement of the amide linker by heterocyclic aromatics and then a ...
The present invention relates to compounds of the formula: ##STR1## These compounds are useful in pharmaceuticals in which cannabis is known to be involved.
6(R)- 2-(8'-acyloxy-2'-methyl-6'-methyl (or hydrogen)- polyhydronaphthyl-1')-ethyl!-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-p yran-2- ones are prepared by acylation of the corresponding 8'-hydroxy compounds. The products are strong inhibitor...
6(R)- 2-(8'-acyloxy-2'-methyl-6'-methyl (or hydrogen)- polyhydronaphthyl-1')-ethyl!-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-p yran-2- ones are prepared by acylation of the corresponding 8'-hydroxy compounds. The products are strong inhibitor...
These compounds exhibit excellent inhibitory activity against α-glucoside hydrolase, thus are useful for hyperglycemic symptoms and various disorders caused by hyperglycemia.
The invention relates primarily to pharmaceutical compositions and medicaments containing a compound of Formula (I), infra as the active ingredient. Also i...
Improved pharmaceutical salts of amlodipine, particularly the besylate salt, and pharmaceutical compositions thereof. These salts find utility as anti-ischaemic and anti-hypertensive agents.
A pharmaceutical composition comprising at least one water insoluble crude fiber and at least one lipase inhibitor. The lipase inhibitor is present in an amount effective for treating adiposity. The lipase inhibitor is selected from lips...
Cholesteryl ester transfer protein inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to elevate certain pla...
Physiologically active substances ML-236 of the formula ##SPC1## Wherein R is hydrogen atom, hydroxy group or 2-methylbutyryloxy group having cholesterol- and lipid-lowering effects in blood and liver and thus utility as hypocholesteremi...
Cholesteryl ester transfer protein inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to elevate certain pla...